Cargando…

Clinical Characteristics of Patients with Drug-induced Liver Injury

BACKGROUND: Drug is an important cause of liver injury and accounts for up to 40% of instances of fulminant hepatic failure. Drug-induced liver injury (DILI) is increasing while the diagnosis becomes more difficult. Though many drugs may cause DILI, Chinese herbal medicines have recently emerged as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Li-Xia, Liu, Cheng-Yuan, Zhang, Lun-Li, Lai, Ling-Ling, Fang, Ming, Zhang, Chong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282672/ https://www.ncbi.nlm.nih.gov/pubmed/28091407 http://dx.doi.org/10.4103/0366-6999.197995

Ejemplares similares

The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis
por: Yang, Jun, et al.
Publicado: (2016)

Clinical characteristics of drug-induced liver injury and related risk factors
por: Lu, Ren-Jie, et al.
Publicado: (2016)

CSH guidelines for the diagnosis and treatment of drug-induced liver injury
por: Yu, Yue-cheng, et al.
Publicado: (2017)

Clinical Characteristics of 162 Patients with Drug-Induced Liver and/or Kidney Injury
por: Wang, Xiaolin, et al.
Publicado: (2020)

Prevalence and clinical characteristics of antibiotics associated drug induced liver injury
por: Park, Jin Hwa, et al.
Publicado: (2021)

The development and application of in silico models for drug induced liver injury
por: Li, Xiao, et al.
Publicado: (2018)

Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration
por: Xiao, Xiaohe, et al.
Publicado: (2019)

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
por: He, Xian, et al.
Publicado: (2022)

Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury
por: Wang, Shuting, et al.
Publicado: (2018)

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
por: Li, Xichuan, et al.
Publicado: (2022)

Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China
por: Zhu, Yun, et al.
Publicado: (2015)

65 Characteristics of Liver Injury in Drug-induced Systemic Hypersensitivity Reactions
por: Park, Chan Sun, et al.
Publicado: (2012)

Drug-Induced Liver Injury: Clinical and Etiologic Features at a Large Tertiary Teaching Hospital in China
por: Liu, Yao, et al.
Publicado: (2020)

Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China
por: Shang, Penghui, et al.
Publicado: (2011)

CD36 deficiency ameliorates drug-induced acute liver injury in mice
por: Zhang, Chen, et al.
Publicado: (2021)

A gene expression profile-based approach to screen the occurrence and predisposed host characteristics of drug-induced liver injury: a case study of Psoralea corylifolia Linn
por: Zhang, Ming-Liang, et al.
Publicado: (2023)

Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury
por: Dong, Huiqun, et al.
Publicado: (2022)

Ibuprofen induced Stevens-Johnson syndrome and liver injury in children: a case report
por: Gui, Ming-Zhu, et al.
Publicado: (2021)

Increased TG to HDL-C ratio is associated with severity of drug-induced liver injury
por: Jia, Xiaoqing, et al.
Publicado: (2023)

MicroRNAs in Drug-induced Liver Injury
por: Li, Li-Min, et al.
Publicado: (2014)

Drug-Induced Liver Injury
por: Almario, Eileen E. N., et al.
Publicado: (2017)

Drug-induced liver injury
por: Suh, Jeong Ill
Publicado: (2019)

Drug-induced liver injury
por: Kumachev, Alexander, et al.
Publicado: (2021)

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury
por: Zeng, Zhan, et al.
Publicado: (2022)

Alternative activation of macrophages by prostacyclin synthase ameliorates alcohol induced liver injury
por: Pan, Xue-yin, et al.
Publicado: (2021)

Clinical Features of Drug-induced Liver Injury According to Etiology
por: Lee, Byoung Moo, et al.
Publicado: (2015)

Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges
por: Jee, Alison, et al.
Publicado: (2021)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
por: Xiao, Ming-He, et al.
Publicado: (2018)

Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment
por: Ho, Cheng-Maw, et al.
Publicado: (2021)

Mercaptopurine/vincristine: Drug-induced liver injury and exacerbation of drug-induced liver injury: case report
Publicado: (2022)

The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China
por: Tuohutaerbieke, Maermaer, et al.
Publicado: (2021)

Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury
por: Xiong, Yu-Ting, et al.
Publicado: (2023)

Clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years
por: Cheng, Ying, et al.
Publicado: (2023)

Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs
por: Zhou, Yongfeng, et al.
Publicado: (2021)

COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
por: Li, Penghui, et al.
Publicado: (2022)

Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods
por: Yang, Hongyi, et al.
Publicado: (2019)

Drug-Induced Liver Injury Induced by Bioflavonoids
por: Pais, João P, et al.
Publicado: (2021)

Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps)
por: Liu, Zhichao, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qfbubhto09l7raci5pj3km76ch